...
ADOS-2 Assessment

Adult Autism ADOS-2 Assessment

Overview

The ADOs-2 is a semi-structured interview assessment that takes 1.5 hours and is for adults who would like to stagger the diagnosis process and receive a diagnosis based on ADOS-2 alone.

We offer a separate booking service as some employment providers may pay towards some of the services we offer, or some adults prefer to receive the results of ADOS-2 first when deciding whether to proceed to a combined assessment.

Some healthcare providers prefer a dual assessment of ADOS-2 and ADI-R and it is best to check with your local NHS or GP if a dual assessment is required. By booking the ADOS-2 and ADI-R separately you will have more financial control over your assessment process. If you have had an ADOS-2 assessment you will need to complete the ADI-R within one year.

ADOS-2 is a standardised set of activities and questions most likely to provide the specialist assessor with a good opportunity to observe Autistic Spectrum Disorder behaviours and traits.

The Autism Diagnostic Observations Schedule – ADOS-2 measures:

  1. Communication
  2. Social Interaction
  3. Play
  4. Restricted and Repetitive Behaviours

The ADOS-2 is suitable for children and adults from pre-verbal to verbal and non-verbal. Testing typically last 40 – 120 minutes.

Related Services

Service Update

Fiona Project is closed and not currently providing ADHD assessment or prescribing services.

Following the resignation of our Clinical Director, and a review of our clinical governance arrangements, we have concluded that the service is unable to continue operating safely under its existing model.

The service is experiencing significant operational difficulties common to remote ADHD service models, particularly in relation to the provision of long-term prescribing without consistent shared care support from NHS Primary Care and access to face-to-face clinical monitoring. The service was not designed to provide long-term ADHD management in the absence of these arrangements.

In addition, without a Clinical Director in post, it would not be clinically appropriate or responsible to continue providing ADHD prescribing. At this time, we are unable to appoint a replacement Clinical Director, and the service will therefore remain closed.

All patients who were previously under our care have been contacted directly and supported through a managed transition of care, including guidance on referral to NHS Integrated Care Board (ICB)-commissioned services or alternative providers where appropriate.

This decision has been taken in the interests of patient safety, regulatory compliance, and good clinical. Further updates will be published on this page should the status of the service change.

Fiona Project Management Team.